• 18212 Citations
  • 52 h-Index
1982 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Melanoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Esophageal Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Safety Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2019

  • 18212 Citations
  • 52 h-Index
  • 203 Article
  • 3 Review article
  • 1 Chapter

An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system

Larkin, J., Brown, M. P., Arance, A. M., Hauschild, A., Queirolo, P., Vecchio, M. D., Ascierto, P. A., Krajsová, I., Schachter, J., Neyns, B., Garbe, C., Sileni, V. C., Mandalà, M., Gogas, H., Espinosa, E., Hospers, G., Lorigan, P., Nyakas, M., Guminski, A., Liszkay, G. & 5 othersRutkowski, P., Miller, W., Donica, M., Makrutzki, M. & Blank, C., Jan 1 2019, In : European Journal of Cancer. 107, p. 175-185 11 p.

Research output: Contribution to journalArticle

Multicenter Studies
Melanoma
Safety
Mutation
PLX4032

An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system

Larkin, J., Brown, M. P., Arance, A. M., Hauschild, A., Queirolo, P., Vecchio, M. D., Ascierto, P. A., Krajsová, I., Schachter, J., Neyns, B., Garbe, C., Sileni, V. C., Mandalà, M., Gogas, H., Espinosa, E., Hospers, G., Lorigan, P., Nyakas, M., Guminski, A., Liszkay, G. & 5 othersRutkowski, P., Miller, W., Donica, M., Makrutzki, M. & Blank, C., Jan 2019, In : European Journal of Cancer. 107, p. 175-185 11 p.

Research output: Contribution to journalArticle

Multicenter Studies
Melanoma
Safety
Mutation
PLX4032
1 Citation (Scopus)

Clonal heterogeneity of melanoma in a paradigmatic case study: Future prospects for circulating melanoma cells

Scaini, M. C., Pigozzo, J., Pizzi, M., Manicone, M., Chiarion-Sileni, V., Zambenedetti, P., Rugge, M., Zanovello, P., Rossi, E., Zamarchi, R. & Facchinetti, A., Feb 1 2019, In : Melanoma Research. 29, 1, p. 89-94 6 p.

Research output: Contribution to journalArticle

Melanoma
Clone Cells
Neoplasm Metastasis
Mutation
Neoplasms
1 Citation (Scopus)
Gene Dosage
Gene Frequency
Melanoma
Chromosomes, Human, Pair 7
Alleles
12 Citations (Scopus)

Current status and perspectives in immunotherapy for metastatic melanoma

Marconcini, R., Spagnolo, F., Stucci, L. S., Ribero, S., Marra, E., de Rosa, F. D., Picasso, V., di Guardo, L. D., Cimminiello, C., Cavalieri, S., Orgiano, L., Tanda, E., Spano, L., Falcone, A., Queirolo, P., Palmieri, G., Stanganelli, I., Mandalà, M., Quaglino, P., Botti, G. & 3 othersCaracò, C., Sileni, V. C. & di Giacomo, A. M., Jan 1 2018, In : Oncotarget. 9, 15, p. 12452-12470 19 p.

Research output: Contribution to journalArticle

Immunotherapy
Melanoma
Immune System Diseases
Drug Combinations
Pharmaceutical Preparations